CK
ELV icon

Carnick & Kubik’s Elevance Health ELV Stock Holding History

Carnick & Kubik’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-8,322
Closed -$1.37M – 415
2015
Q2 		$1.37M Buy
8,322
+137
+2% +$21.9K 1.12% 21
2015
Q1 		$1.26M Buy
8,185
+349
+4% +$49.7K 1.05% 27
2014
Q4 		$985K Buy
7,836
+120
+2% +$14.8K 0.84% 34
2014
Q3 		$923K Buy
+7,716
New +$885K 0.85% 37

Other funds holding ELV

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Carnick & Kubik's ELV Position: Q3 2015 in Review

Carnick & Kubik sold out of Elevance Health (ELV) in Q3 2015, closing a stake of 8,322 shares — an estimated $1.37M sold.

Carnick & Kubik first reported a position in ELV in Q3 2014 and held it in 4 quarters. The position peaked at $1.37M in Q2 2015. 760 funds tracked by Wall St. Rank hold ELV as of Q3 2015.

  • Carnick & Kubik reported no remaining Elevance Health position as of Q3 2015 after selling out during the quarter.
  • Carnick & Kubik sold 8,322 Elevance Health shares in Q3 2015, an estimated $1.37M.
  • Carnick & Kubik first reported a position in Elevance Health in Q3 2014 and held it in 4 quarters.
  • Carnick & Kubik's Elevance Health position peaked at $1.37M in Q2 2015.
  • 760 funds tracked by Wall St. Rank held Elevance Health as of Q3 2015.

Based on Carnick & Kubik's 13F filing for Q3 2015, filed 13 Nov 2015.